期刊文献+

Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease 被引量:1

Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease
原文传递
导出
摘要 Background The relationship between symptom elimination and normalization of esophageal acid level of gastroesophageal reflux disease (GERD) on proton-pump inhibitor (PPI) therapy has been questioned. This study aimed to evaluate the relationship between symptom response and gastro-esophageal acidity control in Chinese patients with GERD on esomeprazole therapy, and to assess the role of 24-hour esophageal pH-metry after therapy in GERD patients.Methods GERD patients with typical reflux symptoms were enrolled and received esomeprazole 40 mg once daily for 4 weeks. Patients with positive baseline 24-hour esophageal pH-metry were divided into two groups depending on an additional dual-channel 24-hour pH-metry after treatment. The pH- group achieved normalization of esophageal pH level whereas the pH+ group did not.Results Of the 80 patients studied, 76 had abnormal baseline esophageal pH levels. Of these, 90% (52/58) of symptom-free patients and 67% (12/18) of symptom-persistent patients achieved esophageal pH normalization after therapy (P=0.030). The mean post-therapy gastric nocturnal percent time of pH 〈4.0 was significantly higher in pH+group than that in pH- group (P 〈0.001) after therapy. The multivariate regression analysis identified hiatus hernia (P〈0.001) and persistent reflux symptom (P=0.004) were two independent factors predicting the low post-therapy esophageal pH level.Conclusions Symptom elimination is not always accompanied by esophageal pH normalization, and vice verse.Esophageal pH-metry is recommended for GERD patients with hiatus hernia or with persistent reflux symptoms after PPI therapy. Background The relationship between symptom elimination and normalization of esophageal acid level of gastroesophageal reflux disease (GERD) on proton-pump inhibitor (PPI) therapy has been questioned. This study aimed to evaluate the relationship between symptom response and gastro-esophageal acidity control in Chinese patients with GERD on esomeprazole therapy, and to assess the role of 24-hour esophageal pH-metry after therapy in GERD patients.Methods GERD patients with typical reflux symptoms were enrolled and received esomeprazole 40 mg once daily for 4 weeks. Patients with positive baseline 24-hour esophageal pH-metry were divided into two groups depending on an additional dual-channel 24-hour pH-metry after treatment. The pH- group achieved normalization of esophageal pH level whereas the pH+ group did not.Results Of the 80 patients studied, 76 had abnormal baseline esophageal pH levels. Of these, 90% (52/58) of symptom-free patients and 67% (12/18) of symptom-persistent patients achieved esophageal pH normalization after therapy (P=0.030). The mean post-therapy gastric nocturnal percent time of pH 〈4.0 was significantly higher in pH+group than that in pH- group (P 〈0.001) after therapy. The multivariate regression analysis identified hiatus hernia (P〈0.001) and persistent reflux symptom (P=0.004) were two independent factors predicting the low post-therapy esophageal pH level.Conclusions Symptom elimination is not always accompanied by esophageal pH normalization, and vice verse.Esophageal pH-metry is recommended for GERD patients with hiatus hernia or with persistent reflux symptoms after PPI therapy.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第15期2012-2017,共6页 中华医学杂志(英文版)
关键词 gastroesophageal reflux ESOMEPRAZOLE symptom response esophageal pH level gastroesophageal reflux esomeprazole symptom response esophageal pH level
  • 相关文献

参考文献22

  • 1Fock KM,Talley NJ,Fass R,Goh KL,Katelaris P,Hunt R,et al.Asia-Pacific consensus on the management of gastroesophageal reflux disease:update.J Gastreenterol Hepatol 2008; 23:8-22.
  • 2Dekel R,Morse C,Fass R.The role of proton pump inhibitors in gastro-oesophageal reflux disease.Drugs 2004; 64:277-295.
  • 3Bytzer P.Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients.Am J Gastroenterol 2003; 98 (3 Suppl):S31-S39.
  • 4Gerson LB,Boparai V,Ullah N,Triadafilopoulos G.Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.Aliment Pharmacol Ther 2004; 15; 20:637-643.
  • 5Milkes D,Gerson LB,Triadafilopoulos G.Complete elimination of reflux symptoms does not guarantee normalization of oesophageal and gastric pH in patients with gastroesophageal reflux disease (GERD).Am J Gastroenterol 2004; 99:991-996.
  • 6Cheung TK,Wong WM,Wong NY,Chan CK,Fung J,Yuen MF,et al.Symptom resolution does not predict healing of erosive oesophagitis in Chinese.Digestion 2007; 75:128-134.
  • 7Katz PO,Ginsberg GG,Hoyle PE,Sostek MB,Monyak JT,Silberg DG.Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.Aliment Pharmacol Ther 2007; 25:617-628.
  • 8Tack J,Keek G,Demedts I,Sifrim D,Janssens J.Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus:acid reflux,bile reflux,or both? Am J Gastroenterol 2004; 99:981-988.
  • 9Armstrong D,Bennett JR,Blum AL,Dent J,De Dombal FT,Galmiche JP,et al.The endoscopic assessment of oesophagits:a progress report on observer agreement.Gastroenterology 1996; 111:85-92.
  • 10Inamori M,Togawa J,Nagase H,Abe Y,Umezawa T,Nakajima A,et al.Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification.J Gastroenterol Hepatol 2003; 18:172-176.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部